{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:41Z","timestamp":1791389321821,"version":"4.3.3"},"reference-count":148,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jaci.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:41:56Z","timestamp":1715938916000},"page":"245-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["TH2-driven manifestations of inborn errors of immunity"],"prefix":"10.1016","volume":"154","author":[{"given":"Alyssa E.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Abdalgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paneez","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.05.007_bib1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.immuni.2018.02.011","article-title":"Recent advances in type-2-cell-mediated immunity: insights from helminth infection","volume":"48","author":"Harris","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2024.05.007_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","article-title":"Mast cells in inflammation and disease: recent progress and ongoing concerns","volume":"38","author":"Galli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","article-title":"Mast cell tryptases in allergic inflammation and immediate hypersensitivity","volume":"72","author":"Lyons","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaci.2013.07.046","article-title":"Basophils and allergic inflammation","volume":"132","author":"Siracusa","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib6","first-page":"357","article-title":"The role of eosinophils in allergic airway inflammation","volume":"9","author":"Walsh","year":"2010","journal-title":"Discov Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/cells10040895","article-title":"Basophils orchestrating eosinophils\u2019 chemotaxis and function in allergic inflammation","volume":"10","author":"Iype","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2024.05.007_bib8","first-page":"1","article-title":"Diagnosed allergic conditions in adults: United States, 2021","volume":"460","author":"Ng","year":"2023","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jaci.2024.05.007_bib9","first-page":"1","volume":"459","author":"Zablotsky","year":"2023"},{"key":"10.1016\/j.jaci.2024.05.007_bib10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2021.08.008","article-title":"Inborn errors of immunity manifesting as atopic disorders","volume":"148","author":"Vaseghi-Shanjani","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-immunol-042718-041553","article-title":"Primary atopic disorders","volume":"38","author":"Milner","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13223-016-0158-5","article-title":"Genetic and epigenetic studies of atopic dermatitis","volume":"12","author":"Bin","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.anai.2016.03.027","article-title":"The clinical relevance of filaggrin mutations: effect on allergic disease","volume":"117","author":"Tenn","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ajhg.2010.07.005","article-title":"Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease","volume":"87","author":"Oji","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2024.05.007_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaci.2015.05.002","article-title":"Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin","volume":"136","author":"McAleer","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ng.2739","article-title":"Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting","volume":"45","author":"Samuelov","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2024.05.007_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2024.05.007_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaci.2022.05.018","article-title":"Filaggrin loss-of-function mutations are associated with persistence of egg and milk allergy","volume":"150","author":"Kalb","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib19","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/all.13143","article-title":"The skin barrier function gene SPINK5 is associated with challenge-proven IgE-mediated food allergy in infants","volume":"72","author":"Ashley","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.05.007_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jdv.17671","article-title":"Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity","volume":"36","author":"Darbord","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2024.05.007_bib21","first-page":"7","article-title":"Dupilumab in the treatment of genodermatosis: a systematic review","volume":"21","author":"Wu","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2024.05.007_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1054422","article-title":"Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation","volume":"13","author":"Yan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1346-8138.16253","article-title":"Successful treatment of Netherton syndrome with dupilumab: a case report and review of the literature","volume":"49","author":"Wang","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib24","first-page":"310","article-title":"Dupilumab improves pruritus in Netherton syndrome: a case study","volume":"9","author":"Inaba","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jaci.2024.05.007_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000514699","article-title":"Netherton syndrome: case report and review of the literature","volume":"7","author":"Herz-Ruelas","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jaci.2024.05.007_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/ced.14317","article-title":"Successful treatment with dupilumab of an adult with Netherton syndrome","volume":"45","author":"Andreasen","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2258","article-title":"Identification of a novel COL7A1 variant associated with dystrophic epidermolysis bullosa pruriginosa responding effectively to dupilumab","volume":"11","author":"Zhao","year":"2023","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/1346-8138.16729","article-title":"Successful treatment of epidermolysis bullosa pruriginosa by dupilumab","volume":"50","author":"Wu","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1600","article-title":"Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin","volume":"9","author":"Zhang","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/pde.14318","article-title":"A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome","volume":"37","author":"Zelieskova","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Com\u00e8l-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.0307-6938.2001.00955.x","article-title":"A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis","volume":"27","author":"Jolles","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.aay5663","article-title":"HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease","volume":"369","author":"Cook","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2024.05.007_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.20110896","article-title":"A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP","volume":"209","author":"Lanzi","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12026-008-8084-3","article-title":"Mutations of the Wiskott-Aldrich syndrome protein affect protein expression and dictate the clinical phenotypes","volume":"44","author":"Ochs","year":"2009","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2024.05.007_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2016.09.061","article-title":"Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency","volume":"140","author":"Kuijpers","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634313","article-title":"Case report: a novel synonymous ARPC1B gene mutation causes a syndrome of combined immunodeficiency, asthma, and allergy with significant intrafamilial clinical heterogeneity","volume":"12","author":"Papadatou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib38","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jaci.2019.02.003","article-title":"A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency","volume":"143","author":"Volpi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib39","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10875-022-01327-0","article-title":"HEM1 actin immunodysregulatory disorder: genotypes, phenotypes, and future directions","volume":"42","author":"Cook","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib40","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1172\/JCI85774","article-title":"A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton","volume":"126","author":"Janssen","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.05.007_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2021.02.025","article-title":"Macabre T(H)2 skewing in DOCK8 deficiency","volume":"148","author":"Janssen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib42","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14209","article-title":"A human immunodeficiency syndrome caused by mutations in CARMIL2","volume":"8","author":"Schober","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2024.05.007_bib44","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mgg3.237","article-title":"A potential founder variant in CARMIL2\/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction","volume":"4","author":"Sorte","year":"2016","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib45","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1084\/jem.20160576","article-title":"Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations","volume":"213","author":"Wang","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib46","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1084\/jem.20141307","article-title":"DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity","volume":"211","author":"Zhang","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib47","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41590-020-0795-1","article-title":"Migration-induced cell shattering due to DOCK8 deficiency causes a type 2-biased helper T cell response","volume":"21","author":"Schneider","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib48","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2022.06.023","article-title":"The role of the CBM complex in allergic inflammation and disease","volume":"150","author":"DeVore","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib49","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2017.06.047","article-title":"Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11)","volume":"141","author":"Dadi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib50","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ng.3898","article-title":"Germline hypomorphic CARD11 mutations in severe atopic disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2024.05.007_bib51","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jaip.2020.04.070","article-title":"Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome","volume":"8","author":"Jamee","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.007_bib52","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221020","article-title":"Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kdelta syndrome 2","volume":"220","author":"Nguyen","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2019.01.033","article-title":"Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells","volume":"144","author":"Bier","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib54","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2024.05.007_bib55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/abbs\/gmab008","article-title":"mTOR pathway regulates the differentiation of peripheral blood Th2\/Treg cell subsets in patients with pemphigus vulgaris","volume":"53","author":"Lai","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jaci.2024.05.007_bib57","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fped.2015.00065","article-title":"Approaches to managing autoimmune cytopenias in novel immunological disorders with genetic underpinnings like autoimmune lymphoproliferative syndrome","volume":"3","author":"Rao","year":"2015","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2024.05.007_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.702872","article-title":"Disorders related to PI3Kdelta hyperactivation: characterizing the clinical and immunological features of activated PI3-kinase delta syndromes","volume":"9","author":"Redenbaugh","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2024.05.007_bib60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/imm.13684","article-title":"Inhibition of PI3K p110delta activity reduces IgE production in IL-4 and anti-CD40 stimulated human B cell cultures","volume":"170","author":"Cutrina-Pons","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2024.05.007_bib61","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1038\/s41598-020-64594-0","article-title":"Roles of PI3K pan-inhibitors and PI3K-delta inhibitors in allergic lung inflammation: a systematic review and meta-analysis","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2024.05.007_bib62","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/bph.14917","article-title":"Phosphatidylinositol 3-kinase-delta controls endoplasmic reticulum membrane fluidity and permeability in fungus-induced allergic inflammation in mice","volume":"177","author":"Lee","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2024.05.007_bib63","first-page":"128","article-title":"PI3K\/mTOR inhibitor dactolisib attenuates allergic response through inhibitions of the sensitization and mast cell activation","volume":"78","author":"Yamaki","year":"2023","journal-title":"Pharmazie"},{"key":"10.1016\/j.jaci.2024.05.007_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jmg.2005.036160","article-title":"Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development","volume":"43","author":"Sanlaville","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaci.2024.05.007_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.GIM.0000105752.80592.A3","article-title":"Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review","volume":"6","author":"Kalman","year":"2004","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1269\/jrr.10017","article-title":"Functions and regulation of Artemis: a goddess in the maintenance of genome integrity","volume":"51","author":"Kurosawa","year":"2010","journal-title":"J Radiat Res"},{"key":"10.1016\/j.jaci.2024.05.007_bib67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s10875-018-0537-4","article-title":"RAG deficiency: two genes, many diseases","volume":"38","author":"Delmonte","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib68","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaci.2009.06.048","article-title":"Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells","volume":"124","author":"Somech","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib69","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bmt.1705017","article-title":"Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience","volume":"36","author":"Mazzolari","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2024.05.007_bib70","series-title":"STAT3 hyper IgE syndrome","author":"Hsu","year":"1993"},{"key":"10.1016\/j.jaci.2024.05.007_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"B\u00e9ziat","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib72","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib73","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib74","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"B\u00e9ziat","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib75","first-page":"1566","article-title":"New dominant-negative IL6ST variants expand the immunological and clinical spectrum of GP130-dependent hyper-IgE syndrome","volume":"43","author":"Arlabosse","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2017.06.248","article-title":"A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients","volume":"90","author":"Ben-Khemis","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib78","doi-asserted-by":"crossref","first-page":"1410-9","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib79","doi-asserted-by":"crossref","first-page":"1400-9","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib80","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2015.07.047","article-title":"Neonatal-onset T(\u2212)B(\u2212)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3","volume":"137","author":"Bernth-Jensen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib81","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jaci.2018.12.987","article-title":"Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients","volume":"143","author":"Ben-Ali","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib82","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.05.007_bib83","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib84","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.05.007_bib85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpeds.2010.12.042","article-title":"STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease","volume":"158","author":"Nadeau","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2024.05.007_bib86","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib87","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.05.007_bib88","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib89","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaci.2023.03.007","article-title":"Germline STAT6 gain-of-function variants cause severe allergy","volume":"151","author":"Yamashita","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib90","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2022.12.802","article-title":"STAT6 gain-of-function variant exacerbates multiple allergic symptoms","volume":"151","author":"Takeuchi","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaci.2022.09.028","article-title":"A germline STAT6 gain-of-function variant is associated with early-onset\u00a0allergies","volume":"151","author":"Suratannon","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib92","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10875-023-01530-7","article-title":"Autosomal dominant STAT6 gain of function causes severe atopy associated with lymphoma","volume":"43","author":"Minskaia","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","article-title":"Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6","volume":"152","author":"Baris","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib94","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2023.06.004","article-title":"Successful treatment of JAK1-associated inflammatory disease","volume":"152","author":"Fayand","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib95","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.007_bib96","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.anai.2023.01.020","article-title":"Oral Janus kinase inhibitors for atopic dermatitis","volume":"130","author":"Mikhaylov","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib97","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","article-title":"Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial","volume":"157","author":"Blauvelt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib98","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations\u201410 children and review of the literature","volume":"42","author":"Dey\u00e0-Mart\u00ednez","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717388","article-title":"Emerging place of JAK inhibitors in the treatment of inborn errors of immunity","volume":"12","author":"Hadjadj","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib100","doi-asserted-by":"crossref","first-page":"195ra94","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGF\u03b2 receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib101","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jaip.2022.01.012","article-title":"Targeted IL-4Ralpha blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-beta signaling due to ERBIN deficiency","volume":"10","author":"Droghini","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.007_bib102","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaci.2011.02.010","article-title":"Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response","volume":"127","author":"Leung","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib103","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jid.2011.374","article-title":"Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum","volume":"132","author":"Gao","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib104","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jaci.2015.06.047","article-title":"Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum","volume":"136","author":"Gao","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/gt.2012.69","article-title":"Regulation of immunological balance by sustained interferon-gamma gene transfer for acute phase of atopic dermatitis in mice","volume":"20","author":"Watcharanurak","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.jaci.2024.05.007_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.831279","article-title":"Inborn errors of immunity associated with type 2 inflammation in the USIDNET registry","volume":"13","author":"Smith","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib107","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00431-005-1745-5","article-title":"Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children","volume":"164","author":"Wood","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2024.05.007_bib108","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaci.2005.11.030","article-title":"Genetic epidemiology of health disparities in allergy and clinical immunology","volume":"117","author":"Barnes","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib109","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1167\/iovs.06-0991","article-title":"Genetic polymorphisms in the promoter of the interferon gamma receptor 1 gene are associated with atopic cataracts","volume":"48","author":"Matsuda","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2024.05.007_bib110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1067\/mai.2001.113051","article-title":"Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma","volume":"107","author":"Nakao","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib111","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/all.14853","article-title":"Eczema herpeticum in atopic dermatitis","volume":"76","author":"Traidl","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.05.007_bib112","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2024.05.007_bib113","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202726","article-title":"High Th2 cytokine levels and upper airway inflammation in human inherited T-bet deficiency","volume":"218","author":"Yang","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi7160","article-title":"Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T\/B cell late differentiation","volume":"7","author":"Hoshino","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-019-00445-7","article-title":"Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis","volume":"20","author":"Eichenfield","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib116","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2017.09.052","article-title":"Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta-analysis of randomized controlled trials","volume":"78","author":"Fleming","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2024.05.007_bib117","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jaci.2023.08.024","article-title":"Dupilumab strengthens herpes simplex virus type 1-specific immune responses in atopic dermatitis","volume":"152","author":"Traidl","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib118","article-title":"Efficacy of dupilumab in treating atopic dermatitis with recurrent eczema herpeticum in a patient with DOCK8-deficiency hyper-IgE syndrome: a case report","volume":"15","author":"Johar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2024.05.007_bib119","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jaip.2022.04.001","article-title":"Atopy as immune dysregulation: offender genes and targets","volume":"10","author":"Vaseghi-Shanjani","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.007_bib120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.iac.2015.05.004","article-title":"Eosinophilia associated with disorders of immune deficiency or immune dysregulation","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2024.05.007_bib121","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1542\/peds.2010-0260","article-title":"A case of severe eosinophilia in a preterm infant","volume":"127","author":"Shahein","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2024.05.007_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.987895","article-title":"Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: data from the USIDNET registry","volume":"13","author":"Tran","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib123","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/annrheumdis-2020-219137","article-title":"Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features","volume":"80","author":"Schwartz","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2024.05.007_bib124","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mayocp.2013.05.021","article-title":"Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study","volume":"88","author":"Urm","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2024.05.007_bib125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2022018546","article-title":"A randomized, placebo-controlled phase 3 trial of the PI3K\u03b4 inhibitor leniolisib for activated PI3K\u03b4 syndrome","volume":"141","author":"Rao","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.05.007_bib126","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2013.08.045","article-title":"Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation","volume":"132","author":"Siegel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib127","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2015.11.024","article-title":"Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis","volume":"138","author":"Hox","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib128","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/all.12416","article-title":"Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern","volume":"69","author":"Boos","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.05.007_bib129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjms.2018.08.005","article-title":"Development of the pediatric gut microbiome: impact on health and disease","volume":"356","author":"Ihekweazu","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaci.2024.05.007_bib130","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/intimm\/dxg148","article-title":"Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells","volume":"15","author":"Pivniouk","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib131","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1172\/JCI85129","article-title":"FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy","volume":"126","author":"Lexmond","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.05.007_bib132","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2019.05.007","article-title":"GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects","volume":"144","author":"Desai","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib133","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone, I: definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib134","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s10875-007-9159-y","article-title":"Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models","volume":"28","author":"Milner","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ACI.0b013e328364ddfd","article-title":"Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions","volume":"13","author":"Kopfnagel","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib136","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nri2433","article-title":"Cytokine-mediated regulation of antimicrobial proteins","volume":"8","author":"Kolls","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib137","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated coccidioidomycosis treated with interferon-gamma and dupilumab","volume":"382","author":"Tsai","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib138","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MCP.0000000000000951","article-title":"Eosinophilic respiratory disorders and the impact of biologics","volume":"29","author":"Bernstein","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100638","article-title":"Dupilumab: an emerging therapy in allergic fungal rhinosinusitis","volume":"15","author":"Bulkhi","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2024.05.007_bib140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.anai.2020.07.014","article-title":"Dupilumab use in recalcitrant allergic fungal rhinosinusitis","volume":"125","author":"Lo","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.12.091","article-title":"Chronic urticaria as possible manifestation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)","volume":"129","author":"Huebner","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib142","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa1500611","article-title":"Vibratory urticaria associated with a missense variant in ADGRE2","volume":"374","author":"Boyden","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib143","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.05.007_bib144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13578-016-0120-8","article-title":"Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis","volume":"6","author":"Ke","year":"2016","journal-title":"Cell Biosci"},{"key":"10.1016\/j.jaci.2024.05.007_bib145","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jaci.2020.12.637","article-title":"Mutation in KARS: a novel mechanism for severe anaphylaxis","volume":"147","author":"Rib\u00f3","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib146","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13223-022-00677-z","article-title":"Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride","volume":"18","author":"Ansotegui","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib147","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaci.2023.08.033","article-title":"Genome-wide meta-analysis implicates variation affecting mast cell biology in urticaria","volume":"153","author":"McSweeney","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.007_bib148","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s42003-023-05079-4","article-title":"Sequence variant affects GCSAML splicing, mast cell specific proteins, and risk of urticaria","volume":"6","author":"Kristjansson","year":"2023","journal-title":"Commun Biol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924005050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924005050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:21:40Z","timestamp":1722856900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924005050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0091674924005050"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.05.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TH2-driven manifestations of inborn errors of immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}